Remer Thomas, Maser-Gluth Christiane, Boye Kai R, Hartmann Michaela F, Heinze Eberhard, Wudy Stefan A
Department of Nutrition and Health, Research Institute of Child Nutrition, Dortmund, Germany.
Steroids. 2006 Jul;71(7):591-8. doi: 10.1016/j.steroids.2006.02.005. Epub 2006 Apr 17.
Reported literature data strongly suggest that steroid metabolism is dysregulated in Type 1 diabetes mellitus. The aim of this study was to non-invasively examine the cortisol metabolism in children with Type 1 diabetes mellitus (T1DM) in detail and to test the hypothesis that adrenarche is affected under conventional intensive insulin therapy. In 24-h urine samples of 109 patients aged 4-18 years with T1DM of more than 1 year, steroids were profiled using gas chromatography-mass spectrometry. Additionally, urinary free cortisol (UFF) and cortisone (UFE) were quantified by RIA after extraction and chromatographic purification. Data on urinary steroids from 400 healthy controls served as reference values. Enzyme activities were assessed by established steroid metabolite ratios, e.g. 5alpha-reductase and 11beta-hydroxysteroid dehydrogenase Type 2 (11beta-HSD2) by 5alpha-tetrahydrocortisol/tetrahydrocortisol and UFE/UFF, respectively. Urinary markers of adrenarche, especially dehydroepiandrosterone and its direct metabolites were elevated in patients, as were urinary 6beta-hydroxycortisol, UFE, and 11beta-HSD2 activity. However, overall cortisol secretion, as reflected by the sum of major urinary cortisol metabolites, was mostly normal and activity of 5alpha-reductase clearly reduced. Our study provides evidence for an exaggerated adrenarche in T1DM children, which may help to understand reported sequelae in female patients like hyperandrogenic symptoms. The findings also suggest a reduced cortisol inactivation via 5alpha-reductase that is not compensated by a fall in cortisol secretion. Whether the elevated urinary 6beta-hydroxycortisol and cortisone excretion, observed in the patients, are also present in other forms of hypercortisolism and may thus serve as non-invasive clinical stress markers deserves further study.
已报道的文献数据强烈表明,1型糖尿病患者存在类固醇代谢失调。本研究的目的是详细地非侵入性检测1型糖尿病(T1DM)儿童的皮质醇代谢,并检验在传统强化胰岛素治疗下肾上腺初现受到影响这一假设。在109例病程超过1年、年龄4 - 18岁的T1DM患者的24小时尿液样本中,使用气相色谱 - 质谱法对类固醇进行分析。此外,尿液游离皮质醇(UFF)和可的松(UFE)在提取和色谱纯化后通过放射免疫分析法进行定量。来自400名健康对照者的尿液类固醇数据用作参考值。通过既定的类固醇代谢物比率评估酶活性,例如分别通过5α - 四氢皮质醇/四氢皮质醇和UFE/UFF评估5α - 还原酶和2型11β - 羟基类固醇脱氢酶(11β - HSD2)。患者的肾上腺初现尿液标志物,尤其是脱氢表雄酮及其直接代谢物升高,尿液6β - 羟基皮质醇、UFE和11β - HSD2活性也升高。然而,主要尿液皮质醇代谢物总和所反映的总体皮质醇分泌大多正常,5α - 还原酶活性明显降低。我们的研究为T1DM儿童肾上腺初现亢进提供了证据,这可能有助于理解女性患者中报道的诸如高雄激素症状等后遗症。研究结果还表明,通过5α - 还原酶的皮质醇失活减少,且未因皮质醇分泌下降而得到补偿。患者中观察到的尿液6β - 羟基皮质醇和可的松排泄升高是否也存在于其他形式的皮质醇增多症中,因此是否可作为非侵入性临床应激标志物,值得进一步研究。